
At Nautilus, we have a big and important mission: positively impact the health and lives of people around the world by unleashing the potential of the proteome. We are developing a single-molecule protein analysis platform of unprecedented sensitivity, scale, and ease of use that we believe will democratize access to the proteome – one of the most dynamic and valuable sources of biological insight. To accomplish this, we are pursuing hard scientific problems with an entrepreneurial mindset and creating a world-class team of builders, innovators, and dreamers across a wide range of disciplines.
We are actively seeking a talented Senior Bioinformatics Scientist to join our growing team. Turning data generated by our platform into reliable proteomic insights depends on assays that are well designed, well optimized, and well understood. In this role, you will partner closely with assay development, reagent, and platform scientists to design experiments, define what success looks like, and translate results into decisions about how our assays should work – whether that means developing a novel assay, optimizing an existing one, or understanding why a result did not go as expected. Doing this well requires connecting the full story of an experiment: the reagent lots that went in, the experimental design, the raw data, how that data was processed, and whether the statistics support the conclusion. We are looking for someone with exceptional communication skills, comfort accessing data wherever it lives, and a strong understanding of experimental work. This role is broad by design and is well suited to someone with a can-do attitude and a genuine desire to learn, who enjoys variety and gets satisfaction from helping teams make good decisions with data
This position will report to a Bioinformatics Fellow. This position is based in San Carlos, CA. A minimum of three days in the office is required.

Born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, Nautilus (Nasdaq: NAUT) set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality.
The extraordinary team at Nautilus represents a wide spectrum of disciplines and expertise, including: protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more.
Nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.